This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Apr;59(4):506-8.

doi: 10.1016/j.eururo.2011.01.029. Epub 2011 Jan 25.

A risk-stratified approach to prostate-specific antigen screening

Christopher J Keto, Stephen J Freedland

PMID: 21292387
DOI: 10.1016/j.eururo.2011.01.029

Editorial

A risk-stratified approach to prostate-specific antigen screening

Christopher J Keto et al. Eur Urol. 2011 Apr.

. 2011 Apr;59(4):506-8.

doi: 10.1016/j.eururo.2011.01.029. Epub 2011 Jan 25.

Authors

Christopher J Keto, Stephen J Freedland

PMID: 21292387
DOI: 10.1016/j.eururo.2011.01.029

No abstract available

PubMed Disclaimer

Comment on

Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam.
Bul M, van Leeuwen PJ, Zhu X, Schröder FH, Roobol MJ. Bul M, et al. Eur Urol. 2011 Apr;59(4):498-505. doi: 10.1016/j.eururo.2011.01.001. Epub 2011 Feb 18. Eur Urol. 2011. PMID: 21334136 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information